Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Thoracic Malignancies
•
Medical Oncology
How would you treat patients with limited-stage small cell lung cancer who have short term contraindications for systemic chemotherapy?
contraindications such as an active infection requiring prolonged antibiotic use.
Related Questions
Would you consider omission of PORT for node+ NSCLC with a positive margin in the setting of a high tumor PD-L1 score and plans for immunotherapy?
Which targeted therapies should we be more cautious of giving after recent immunotherapy in NSCLC?
How would you treat Stage III unresectable adenocarcinoma of the lung with a BRAF-V600E mutation?
What is your approach for an RA patient with lung cancer who is starting immunotherapy?
Would you consider using IO alone for lung cancer patients who are PDL1 <1 but have high TMB?
When do you offer SBRT for a small, slowly growing lung lesion?
Would you consider switching capmatinib to tepotinib or vice versa due to grade 3 hepatotoxicity in a patient with metastatic NSCLC with MET Exon 14 skipping mutation?
What would be your approach in a patient who presented with a solitary brain metastasis that resolved after chemo without local therapy?
What factors do you use when selecting which NGS platform to use for sequencing solid tumors?
How would you manage a patient with stage IV EGFR L858R mutation but with a debilitating drug rash from osimertinib?